Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. uri icon

authors

  • Cavallari, Larisa H
  • Dave, Chintan V
  • Pratt, Victoria M
  • Alestock, Tameka D
  • Anderson, R David
  • Alsip, Jorge
  • Ardati, Amer K
  • Brott, Brigitta C
  • Brown, Lawrence
  • Chumnumwat, Supatat
  • Clare-Salzler, Michael J
  • Lee, Craig R
  • Coons, James C
  • Denny, Joshua C
  • Dillon, Chrisly
  • Elsey, Amanda R
  • Hamadeh, Issam S
  • Harada, Shuko
  • Hillegass, William B
  • Hines, Lindsay
  • Horenstein, Richard B
  • Howell, Lucius A
  • Beitelshees, Amber L
  • Jeng, Linda J B
  • Kelemen, Mark D
  • Lee, Yee Ming
  • Magvanjav, Oyunbileg
  • Montasser, May
  • Nelson, David R
  • Nutescu, Edith A
  • Nwaba, Devon C
  • Pakyz, Ruth E
  • Palmer, Kathleen
  • Cooper-DeHoff, Rhonda M
  • Peterson, Josh F
  • Pollin, Toni I
  • Quinn, Alison H
  • Robinson, Shawn W
  • Schub, Jamie
  • Skaar, Todd C
  • Smith, D Max
  • Sriramoju, Vindhya B
  • Starostik, Petr
  • Stys, Tomasz P
  • Duarte, Julio D
  • Stevenson, James M
  • Varunok, Nicholas
  • Vesely, Mark R
  • Wake, Dyson T
  • Weck, Karen E
  • Weitzel, Kristin W
  • Wilke, Russell A
  • Willig, James
  • Zhao, Richard Y
  • Kreutz, Rolf P
  • Voora, Deepak
  • Stouffer, George A
  • Empey, Philip E
  • Limdi, Nita A
  • Shuldiner, Alan R
  • Winterstein, Almut G
  • Johnson, Julie A
  • Kimmel, Stephen E
  • McDonough, Caitrin W
  • Gong, Yan

publication date

  • November 1, 2017